Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

被引：0
|
作者：
Manaka, Dai
Shiozawa, Manabu
Kotaka, Masahito
Gamoh, Makio
Shiomi, Akio
Makiyama, Akitaka
Munemoto, Yoshinori
Rikiyama, Toshiki
Fukunaga, Mutsumi
Ueki, Takashi
Shitara, Kohei
Shinkai, Hiroshi
Tanida, Nobuyuki
Oki, Eiji
Yamazaki, Kentaro
Sunami, Eiji
Yamanaka, Takeharu
Yoshino, Takayuki
Ohtsu, Atsushi
Maehara, Yoshihiko
机构：
[1] Kyoto Katsura Hosp, Kyoto, Japan
[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
[3] Sano Hosp, Gastrointestinal Canc Ctr, Kobe, Hyogo, Japan
[4] Osaki Citizen Hosp, Dept Med Oncol, Osaki, Japan
[5] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[6] Japan Community Hlth Care Org, Kyushu Hosp, Dept Hematol Oncol, Kitakyushu, Fukuoka, Japan
[7] Fukui Ken Saiseikai Hosp, Fukui, Japan
[8] Jichi Med Univ, Saitama, Japan
[9] Hyogo Prefectural Nishinomiya Hosp, Nishinomiya, Hyogo, Japan
[10] Hamanomachi Hosp, Dept Surg, Fukuoka, Japan
[11] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[12] Chigasaki Municipal Hosp, Dept Surg, Chigasaki, Kanagawa, Japan
[13] Japanese Red Cross Kochi Hosp, Dept Surg, Kochi, Japan
[14] Kyushu Univ, Fukuoka, Japan
[15] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[16] Japanese Red Cross Med Ctr, Dept Surg Oncol, Tokyo, Japan
[17] Yokohama City Univ, Sch Med, Dept Biostat, Yokohama, Kanagawa, Japan
[18] Kyushu Cent Hosp, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4011
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival
    Laurent, Viviana E.
    Vanesa Torbidoni, Ana
    Sampor, Claudia
    Ottaviani, Daniela
    Vazquez, Valeria
    Gabri, Mariano R.
    Garcia de Davila, Maria Teresa
    Ramirez-Ortiz, Marco A.
    Noemi Alonso, Cristina
    Rossi, Jorge
    Alonso, Daniel F.
    Chantada, Guillermo L.
    JAMA OPHTHALMOLOGY, 2016, 134 (12) : 1374 - 1379
  • [22] CHALLENGE: A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21)
    Vardy, Janette L.
    Collett, Gemma
    Burge, Matthew E.
    Bonaventura, Tony
    Rai, Sunil
    Zalcberg, John R.
    Clarke, Stephen J.
    Courneya, Kerry S.
    O'Callaghan, Christopher J.
    Booth, Christopher M.
    Dhillon, Haryana M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 207 - 207
  • [23] MULTIPLE HIGH-RISK FEATURES IN STAGE II COLON CARCINOMA PORTEND WORSE SURVIVAL THAN STAGE III DISEASE.
    Herritt, B. C.
    Castellucci, C.
    Hajirawala, L.
    Yi, Y.
    Klinger, A.
    Orangio, G. R.
    Davis, K.
    Barton, J. S.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [24] Prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC).
    Dienstmann, Rodrigo
    Tejpar, Sabine
    Sinicrope, Frank A.
    Phipps, Amanda I.
    Bot, Brian
    Friend, Stephen Henry
    Delorenzi, Mauro
    Newcomb, Polly A.
    Sargent, Daniel J.
    Jessup, John M.
    Guinney, Justin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer
    Mohamed, Amr
    Jiang, Renjian
    Philip, Philip A.
    Diab, Maria
    Behera, Madhusmita
    Wu, Christina
    Alese, Olatunji
    Shaib, Walid L.
    Gaines, Tyra M.
    Balch, Glen G.
    El-Rayes, Bassel F.
    Akce, Mehmet
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [27] Tumor budding as an index to identify high-risk patients with stage II colon cancer
    Nakamura, Takatoshi
    Mitomi, Hiroyuki
    Kanazawa, Hideki
    Ohkura, Yasuo
    Watanabe, Masahiko
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 568 - 572
  • [28] Risk factors for recurrence in patients with high-risk stage II colon cancer after curative resection
    Ohge, H.
    Sadahiro, S.
    Sakamoto, K.
    Tsuchiya, T.
    Takahashi, T.
    Sato, T.
    Kondo, K.
    Ogata, Y.
    Baba, H.
    Itabashi, M.
    Ikeda, M.
    Hamada, M.
    Kusano, M.
    Hyodo, I.
    Sakamoto, J.
    Taguri, M.
    Morita, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S417 - S417
  • [29] Multiparametric MRI radiomics for predicting disease-free survival and high-risk histopathological features for tumor recurrence in endometrial cancer
    Renton, Mary
    Fakhriyehasl, Mina
    Weiss, Jessica
    Milosevic, Michael
    Laframboise, Stephane
    Rouzbahman, Marjan
    Han, Kathy
    Jhaveri, Kartik
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [30] The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features
    Erdur, Erkan
    Yildirim, Ozgen Ahmet
    Poyraz, Kerem
    Aslan, Ferit
    Yildiz, Fatih
    Komek, Halil
    POSTGRADUATE MEDICINE, 2021, 133 (06) : 694 - 700
12345